Simcere Pharmaceutical Group Limited (FRA:S2P)
Germany flag Germany · Delayed Price · Currency is EUR
0.9550
+0.0050 (0.53%)
Last updated: May 13, 2025

FRA:S2P Statistics

Total Valuation

FRA:S2P has a market cap or net worth of EUR 2.38 billion. The enterprise value is 2.29 billion.

Market Cap 2.38B
Enterprise Value 2.29B

Important Dates

The last earnings date was Thursday, May 8, 2025.

Earnings Date May 8, 2025
Ex-Dividend Date Jun 18, 2025

Share Statistics

Current Share Class 2.47B
Shares Outstanding n/a
Shares Change (YoY) -3.40%
Shares Change (QoQ) -2.52%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 683.93M

Valuation Ratios

The trailing PE ratio is 24.48 and the forward PE ratio is 16.78.

PE Ratio 24.48
Forward PE 16.78
PS Ratio 2.71
PB Ratio 2.54
P/TBV Ratio 3.04
P/FCF Ratio 17.36
P/OCF Ratio 12.90
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.03, with an EV/FCF ratio of 16.70.

EV / Earnings 23.56
EV / Sales 2.82
EV / EBITDA 13.03
EV / EBIT 16.48
EV / FCF 16.70

Financial Position

The company has a current ratio of 2.00, with a Debt / Equity ratio of 0.17.

Current Ratio 2.00
Quick Ratio 1.73
Debt / Equity 0.17
Debt / EBITDA 0.84
Debt / FCF 1.17
Interest Coverage 16.29

Financial Efficiency

Return on equity (ROE) is 10.26% and return on invested capital (ROIC) is 8.37%.

Return on Equity (ROE) 10.26%
Return on Assets (ROA) 6.33%
Return on Invested Capital (ROIC) 8.37%
Return on Capital Employed (ROCE) 12.90%
Revenue Per Employee 133,361
Profits Per Employee 14,736
Employee Count 6,584
Asset Turnover 0.59
Inventory Turnover 1.80

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +40.44% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +40.44%
50-Day Moving Average 0.94
200-Day Moving Average 0.81
Relative Strength Index (RSI) 50.13
Average Volume (20 Days) 61

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, FRA:S2P had revenue of EUR 878.05 million and earned 97.02 million in profits. Earnings per share was 0.04.

Revenue 878.05M
Gross Profit 704.61M
Operating Income 149.97M
Pretax Income 108.50M
Net Income 97.02M
EBITDA 179.50M
EBIT 149.97M
Earnings Per Share (EPS) 0.04
Full Income Statement

Balance Sheet

The company has 257.13 million in cash and 160.04 million in debt, giving a net cash position of 97.09 million.

Cash & Cash Equivalents 257.13M
Total Debt 160.04M
Net Cash 97.09M
Net Cash Per Share n/a
Equity (Book Value) 935.33M
Book Value Per Share 0.38
Working Capital 362.42M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 184.09 million and capital expenditures -47.24 million, giving a free cash flow of 136.85 million.

Operating Cash Flow 184.09M
Capital Expenditures -47.24M
Free Cash Flow 136.85M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 80.25%, with operating and profit margins of 17.08% and 11.05%.

Gross Margin 80.25%
Operating Margin 17.08%
Pretax Margin 12.36%
Profit Margin 11.05%
EBITDA Margin 20.44%
EBIT Margin 17.08%
FCF Margin 15.59%

Dividends & Yields

This stock pays an annual dividend of 0.02, which amounts to a dividend yield of 2.19%.

Dividend Per Share 0.02
Dividend Yield 2.19%
Dividend Growth (YoY) 1.99%
Years of Dividend Growth 1
Payout Ratio 54.76%
Buyback Yield 3.40%
Shareholder Yield 5.58%
Earnings Yield 4.08%
FCF Yield 5.76%
Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

FRA:S2P has an Altman Z-Score of 3.5.

Altman Z-Score 3.5
Piotroski F-Score n/a